Systemic Lupus Erythematosus (SLE): Symptoms, Treatment, and Living with Lupus

What is Systemic Lupus Erythematosus (SLE)?

Lupus, also known as systemic lupus erythematosus (SLE) in its most common form, is a chronic autoimmune disease in which the immune system mistakenly attacks the body’s own tissues and organs. Lupus can affect multiple organ systems, including:

• Joints
• Skin
• Kidneys
• Heart
• Lungs
• Blood vessels
• Brain and nervous system

The exact cause of lupus is not fully understood. Because so many different organs can be affected, symptoms are highly variable between patients and may include:

• Muscle pain and joint pain
• Fever
• A characteristic butterfly-shaped facial rash (malar rash)
• Hair loss
• Pale or bluish fingers and toes (Raynaud’s phenomenon)
• Sun sensitivity (photosensitivity)
• Swelling in the legs and around the eyes
• Mouth ulcers
• Swollen lymph nodes
• Persistent fatigue

Because many of these symptoms overlap with those of numerous other conditions, lupus is sometimes called “the great imitator”. Its presentations are ambiguous and often elusive. Combined with the fact that no single test can confirm the diagnosis, lupus frequently requires considerable time and specialist evaluation to correctly identify.

Types of Lupus

Several forms of lupus exist:

• Systemic lupus erythematosus (SLE): The most common form; can range from mild to severe and affect multiple organs.
• Discoid lupus erythematosus: Causes a persistent red skin rash; rarely progresses to SLE.
• Subacute cutaneous lupus erythematosus (SCLE): Characterized by photosensitivity and skin lesions in sun-exposed areas; typical of Caucasian women.
• Drug-induced lupus: Triggered by certain medications; resolves upon discontinuation of the causative drug.
• Neonatal lupus: A rare form affecting newborns; caused by the passage of maternal antibodies and typically resolves within months.

There is currently no definitive cure for lupus, but with appropriate medication and a careful lifestyle, most patients can achieve and maintain a satisfying quality of life. The main therapeutic goals are:

• Preventing flares (periods of worsening disease)
• Treating symptoms when they occur
• Minimizing organ damage and other long-term complications

Lupus is NOT contagious: it cannot be transmitted from one person to another!

---

Causes

To understand lupus, it helps to understand the immune system, which includes:

• Specialized blood cells, such as white blood cells (leukocytes), play crucial roles in the body
• Chemical substances produced by these cells, known as antibodies

Normally, the immune system recognizes and attacks foreign invaders, such as viruses, bacteria, and other pathogens, while leaving the body’s own healthy cells untouched. In lupus, however, this recognition system fails: the immune system mistakenly identifies the body’s own tissues as threats and launches an immune attack against them, causing inflammation and damage to multiple organs and tissues.

Why this happens is not yet fully understood. Current research suggests that lupus results from a complex interaction of:

• Genetic factors: Certain genes increase susceptibility to lupus, though having these genes does not guarantee disease development. Only about 10% of lupus patients have a parent or sibling with the disease.
• Environmental triggers: UV light (sunlight), stress, smoking, certain infections, and some medications can trigger or worsen symptoms in genetically predisposed individuals.
• Hormonal factors: Lupus is significantly more common in women of reproductive age, leading researchers to investigate the possible role of oestrogen in disease susceptibility and activity.

Risk Factors

While anyone can develop lupus, the most important risk factors are:

• Sex: Women are significantly more affected than men, accounting for approximately 90% of cases. This trend aligns with the pattern seen in most autoimmune diseases.
• Ethnicity: Non-Caucasian ethnic groups (particularly Black, Hispanic, and Asian women) tend to develop lupus more frequently and with greater severity.
• Age: Lupus most commonly begins between the ages of 15 and 44 (the reproductive years for women); it is relatively uncommon in children and older adults.

Types of Lupus

---

Symptoms

Lupus can affect many different parts of the body, but each patient’s experience is unique. One person may have swollen knees and fever; another may primarily experience fatigue and kidney problems; yet another may suffer mainly from skin rashes. Most patients typically experience symptoms involving two or three body systems, while manifesting all possible symptoms simultaneously is extremely rare.

Most Common Symptoms

• Profound fatigue, one of the most disabling and universal symptoms
• Joint pain or swelling (arthritis)
• Fever of unknown origin
• Skin rashes: The classic butterfly (malar) rash across the cheeks and nose is highly characteristic. Photosensitivity also causes these rashes to worsen after sun exposure
• Kidney problems (lupus nephritis), often detected through laboratory tests before they cause symptoms

Additional Symptoms

• Chest pain
• Hair loss (alopecia)
• Anemia (reduced haemoglobin and red blood cell count)
• Mouth ulcers
• Pale or bluish fingers or toes triggered by cold or stress (Raynaud’s phenomenon)
• Migraines
• Dizziness/vertigo
• Depression
• Mental confusion
• Seizures

New symptoms can continue to appear years after initial diagnosis, and the pattern of symptoms may shift and change over time.

Flares

Most lupus patients experience flares, periods when the disease becomes more active and symptoms worsen. Flares may be clinically obvious or detected only through laboratory deterioration.

Common flare triggers include:

• Fatigue and sleep deprivation
• Emotional or physical stress
• Sun exposure (UV light, whether natural or artificial)
• Infections
• Physical injury or trauma
• Stopping or missing medication
• Certain medications

Warning signs of an approaching flare often include:

• Increased fatigue
• Worsening pain
• New skin rash
• Fever
• Stomach pain
• Headache or dizziness

When these appear, the patient should contact their doctor promptly.

---

Complications

Many people with lupus live long and productive lives. However, lupus can be life-threatening in severe cases. Encouragingly, statistics show a progressive and consistent improvement in life expectancy for lupus patients over recent decades, driven by advances in treatment.

Infections remain the leading cause of death in people with lupus.

Lupus can also cause significant physical, mental, and social limitations. Major organ-specific complications include:

• Kidneys: Lupus nephritis impairs the kidneys’ ability to filter waste and toxins. Signs include dark urine, swelling (oedema) around the eyes, legs, and ankles. Kidney involvement requires intensive treatment to prevent permanent damage.

• Lungs: Pleuritis (inflammation of the lung lining) causes chest pain on breathing; pneumonia episodes may also occur.

• Central nervous system: Headache, vertigo, depression, memory problems, seizures, stroke, and behavioral changes.

• Blood vessels: Vasculitis (blood vessel inflammation); increased risk of atherosclerosis and cardiovascular disease.

• Blood: Haemolytic anaemia, leucopenia, thrombocytopenia, and an increased risk of blood clots (due to antiphospholipid antibodies).

• Heart: Inflammation can affect different parts of the heart, such as the muscle (myocarditis), the inner lining (endocarditis), or the surrounding membrane (pericarditis).

---

Diagnosis

The diagnosis of SLE follows internationally standardized criteria (EULAR/ACR 2019 classification criteria), requiring an integrated assessment of clinical signs and laboratory findings. No single test can confirm lupus. Instead, diagnosis involves assembling a complex clinical “puzzle”.

Diagnostic Workup

1. ANA (antinuclear antibodies) test

• The foundational first step. A positive ANA test (titre ≥ 1:80) is the required entry criterion for further investigation. However, ANA positivity alone is not diagnostic, as it can occur in healthy individuals and in other conditions.

2. Specific immunological tests

• Anti-dsDNA (anti-double-stranded DNA) and anti-Smith (anti-Sm) antibodies: Highly specific for SLE; positive findings strongly support the diagnosis
• Antiphospholipid antibodies: Identify patients at increased risk of blood clots and complications in pregnancy
• Complement levels (C3 and C4): Low complement levels indicate immune system activation and active disease

3. Haematological and biochemical tests

• Complete blood count to detect haemolytic anaemia, leucopenia (low white blood cells), or thrombocytopenia
• Kidney and liver function tests

4. Urinalysis

• Essential for early detection of renal involvement, this process focuses on identifying proteinuria (protein in urine) and haematuria (blood in urine).

5. Multisystem clinical assessment

• The physician evaluates for characteristic findings: butterfly rash, non-erosive arthritis, serositis (inflammation of lung or heart membranes), and neuropsychiatric manifestations.

6. Organ biopsy

• When kidney involvement is suspected, renal biopsy is the gold standard for confirming lupus nephritis, classifying its severity (WHO Class I–VI), and guiding treatment intensity. Atypical skin lesions may require skin biopsy for confirmation.

---

Treatment

The modern therapeutic goal for lupus extends beyond symptom control. Instead, it focuses on achieving complete remission or the lowest possible disease activity state, known as LLDAS (Lupus Low Disease Activity State). This approach prevents irreversible organ damage and minimizes the long-term burden of corticosteroid use.

Core and Advanced Pharmacological Therapy

Hydroxychloroquine (Plaquenil), the cornerstone of SLE therapy

• An antimalarial drug that has become the backbone of treatment for all lupus patients (barring rare contraindications). It reduces flare frequency, provides long-term organ protection, and improves survival. All SLE patients should receive hydroxychloroquine unless specifically contraindicated.

Glucocorticoids (Corticosteroids)

• Cortisone and derivatives are used for managing acute flares. The current approach aims to use the lowest effective dose for the shortest necessary duration, to minimize serious long-term side effects including osteoporosis, infections, and cardiovascular risk.

Immunosuppressants

• Drugs such as mycophenolate mofetil, azathioprine, and methotrexate modulate the immune response and are particularly used when kidneys or the nervous system are involved, or when corticosteroid-sparing is a priority.

Biological and Biotechnological Agents

• Monoclonal antibodies represent the most innovative therapeutic frontier:
  • Belimumab (Benlysta): Targets the B-lymphocyte stimulator (BLyS/BAFF), reducing B-cell-driven autoimmunity; approved for active SLE and lupus nephritis
  • Anifrolumab (Saphnelo): Targets the interferon receptor, blocking the interferon pathway central to SLE pathogenesis; approved for moderate-to-severe SLE
  • Both allow significant reduction in corticosteroid exposure

Calcineurin inhibitors

• Voclosporin, a newer calcineurin inhibitor, has been specifically approved for lupus nephritis. It significantly improves rates of complete renal response and long-term preservation of kidney function.

Managing Complications and Prevention

A major focus of modern lupus care is cardiovascular risk management, since patients with SLE have significantly elevated rates of premature atherosclerosis. Key measures include:

• Monitoring and treating hypertension and hypercholesterolaemia
• Vaccination (following specialist-appropriate schedules) to prevent infections, which are the leading cause of mortality in lupus
• Bone health monitoring with calcium and vitamin D supplementation, and bone density screening (given the risk of corticosteroid-induced osteoporosis)

Lifestyle as Clinical Support

Lifestyle modifications are not optional but an integral part of lupus management:

• Sun protection: Broad-spectrum sunscreen (SPF 50+) and protective clothing are mandatory, as UV radiation is one of the primary immunological triggers of disease activity
• Balanced diet: Rich in calcium and vitamin D to support bone health; anti-inflammatory foods (see below)
• Regular physical activity: Helps combat chronic fatigue and maintain joint flexibility. It must be planned with the physician to avoid joint overload

---

Lifestyle Recommendations

Despite symptoms and potential treatment side effects, patients with lupus can aspire to an excellent quality of life with appropriate management, self-awareness, and specialist support.

Key Lifestyle Strategies

• Avoid or limit sun exposure, one of the most important protective measures
• Stop smoking: Smoking cessation has been shown to be beneficial in lupus management
• Practice regular moderate physical activity, tailored to your capacity and planned with your medical team
• Prioritize rest and sleep. Energy management is essential: learn to pace yourself and rest before you become exhausted
• Manage stress: Mindfulness, relaxation techniques, and psychological support are genuinely beneficial
• Take medications consistently as prescribed. Stopping treatment is one of the most common flare triggers
• Set realistic priorities: Avoid overcommitting; work and activities should be adapted to your current capacity
• Join a support group: Peer support and psychological counseling can make a meaningful difference in coping and quality of life

Recognizing Early Warning Signs of a Flare

Learning to recognize the early signals of an approaching flare can help you seek medical attention promptly:

• Increasing fatigue
• Worsening pain
• New or worsening skin rash
• Fever
• Stomach discomfort
• Headache or dizziness

Diet and Nutrition

There is currently no specific dietary protocol validated for SLE. Beyond a generally healthy and varied diet, specific dietary claims lack consistent scientific support.

From an anti-inflammatory perspective, the following may be beneficial:

• Foods rich in antioxidants: fresh fruit and vegetables (especially colorful and leafy greens)
• Foods rich in polyunsaturated fatty acids: omega-3 fatty acids from oily fish, walnuts, flaxseeds, chia seeds
• Adequate calcium and vitamin D intake for bone health (especially important for patients on long-term corticosteroids)
• Balanced caloric intake to maintain a healthy body weight

There is no evidence that specific foods cause lupus or trigger the autoimmune process. However, some patients anecdotally notice that certain dietary habits influence their energy levels and symptom patterns. Keeping a personal food and symptom diary can help identify individual sensitivities.

---

Lupus and Pregnancy

Women with lupus can become pregnant and have healthy babies, but lupus pregnancy is considered high-risk and requires careful planning and specialist monitoring throughout.

Key Considerations

Pre-conception planning

• The disease should be in remission or well-controlled for at least 6 months before conception. Becoming pregnant during active disease significantly increases the risks of miscarriage and other serious complications.

Flares during pregnancy

• Some women experience flares during pregnancy. These typically occur in the first or second trimester or in the early postpartum period. Fortunately, most flares during pregnancy are mild and manageable.

Preeclampsia risk

• Preeclampsia, a serious condition that causes high blood pressure and organ damage and develops after 20 weeks, occurs in approximately 2 in 10 pregnant women with lupus. Symptoms include sudden weight gain, swelling of the hands and face, blurred vision, dizziness, and epigastric pain.

Gestational complications

• Women with lupus on corticosteroids have higher rates of hypertension, gestational diabetes, and kidney complications during pregnancy.

Very high-risk situations

• Some women with lupus encounter especially high pregnancy risks for both themselves and the fetus. This is particularly true for those with severe pulmonary hypertension, significant lung disease, heart failure, or chronic renal failure. These cases require specialized pre-pregnancy counseling.

Neonatal Outcomes

• Babies born to women with lupus do not have significantly higher rates of birth defects or intellectual disability compared to the general population.
• Approximately 1–2% of babies born to lupus mothers will develop neonatal lupus. This condition is related to the passage of maternal antibodies. It typically requires monitoring (especially for cardiac involvement) but resolves spontaneously within 3–6 months.

Breastfeeding

Breastfeeding is generally possible for mothers with lupus. However, because some medications used to treat lupus may pass into breast milk, it is essential to discuss the specific medication regimen with the rheumatologist and neonatologist. Breastfeeding can be physically demanding, and a mixed feeding approach may sometimes be advisable.

---

Frequently Asked Questions

What is lupus?

Lupus refers to a group of autoimmune diseases characterized by the immune system attacking the body’s own tissues. When used without further specification, it typically refers to systemic lupus erythematosus (SLE), the most common form.

What are the symptoms of SLE? How does it manifest?

Symptoms are numerous, varied, and highly individual. They can change significantly over time and from one patient to another. This variability earns lupus its nickname “the great imitator”. Common early symptoms include:

• Fever
• Persistent fatigue
• General malaise
• Muscle and joint pain
• Temporary cognitive difficulties (“brain fog”)

What is the life expectancy with lupus?

SLE is currently incurable but highly treatable. Today, the majority of patients have a life expectancy similar to the general population, particularly with early diagnosis and appropriate treatment.

Which specialist treats lupus?

The primary specialist for lupus is a rheumatologist. However, given lupus’s multi-organ nature, management often involves a multidisciplinary team including immunologists, nephrologists, dermatologists, neurologists, and others depending on which organs are affected.

Can lupus be cured?

Lupus is a chronic condition, so a complete and permanent cure is not currently possible. However, the disease can enter sustained remissions, sometimes lasting for years, and modern treatments allow the vast majority of patients to live full and productive lives.

Is lupus hereditary? Is there a risk for children?

Lupus is not directly hereditary, but there is a degree of familial predisposition. A child of a parent with lupus may have a somewhat higher risk of developing the disease. However, this is far from certain, as most children of lupus patients will never develop the condition. Only about 10% of lupus patients have a first-degree relative (parent, sibling) with the disease.

---

Sources and Bibliography

• National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) – Lupus
• U.S. Department of Health & Human Services – WomensHealth.gov – Lupus
• Lupus Foundation of America – Prognosis and Life Expectancy
• Fangtham M, Hiraki LT, Costenbader KH. Non-pharmacologic therapies in systemic lupus erythematosus. Lupus. 2019.
• Aringer M, et al. European Alliance of Associations for Rheumatology (EULAR)/American College of Rheumatology (ACR) 2019 Classification Criteria for Systemic Lupus Erythematosus. Arthritis & Rheumatology. 2019;71(9):1400–1412.
• Morand EF, et al. Trial of Anifrolumab in Active Systemic Lupus Erythematosus. New England Journal of Medicine. 2020;382(3):211–221.
• Rovin BH, et al. Efficacy and safety of voclosporin versus placebo for lupus nephritis. The Lancet. 2021;397(10289):2070–2080.